ENZC

ENZOLYTICS INC by Enzolytics Inc. (ENZC)

About ENZOLYTICS INC by Enzolytics Inc. (ENZC)

Enzolytics, Inc. is a biotechnology company, which engages in the development and commercialization of drugs for infectious disease treatments. The company’s all-human monoclonal antibodies target and neutralize human immunodeficiency virus and are being employed to produce anti-SARS-CoV-2 monoclonal antibodies for treating COVID-19. Its proprietary therapeutic is also being tested against Hepatitis A, B and C, Rheumatoid Arthritis, certain forms of cancer, rabies, influenza A and B, tetanus, and diphtheria. The company was founded on July 28, 2004 and is headquartered in Allen, TX.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
966,200
Dividend yield
0.00%
Volume
--
Avg. volume
4.4M
P/E ratio
-2.00

ENZOLYTICS INC by Enzolytics Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
966,200
Dividend yield
0.00%
Volume
--
Avg. volume
4.4M
P/E ratio
-2.00